← All entitiesClear entity filter

Healthcare > Gene Therapy

Tracking since May 19, 2026 · Latest signal Apr 23, 2026 · 10 matched data points

Overall sentiment

Positive 100% (10)Negative 0% (0)Neutral 0% (0)

Daily sentiment

Claims (2)

Claims contributing to this aggregate. Confirmed negative claims count as negative impact; confirmed positive claims count as positive impact.

Gene therapy has successfully restored sight in a six-year-old girl.
Parent: HealthcareEntity: Gene TherapyImpact: positiveDate: Apr 22, 2026 - Apr 23, 2026Target: Gene therapy's effectiveness in treating visual impairments8 matched entries8 confirmed0 disputed0 neutral0 unclear
Luxturna gene therapy has been successfully used to improve vision in a six-year-old child with Leber's Congenital Amaurosis.
Parent: HealthcareEntity: Gene TherapySub-entity: LuxturnaImpact: positiveDate: Apr 23, 2026Target: Luxturna gene therapy's effectiveness in treating Leber's Congenital Amaurosis in young children2 matched entries2 confirmed0 disputed0 neutral0 unclear